Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 242 for “"Epithelial Ovarian Cancer"”.

  1. N-Glycosylation signatures of epithelial ovarian cancer

    Despite intense research efforts, epithelial ovarian cancer (EOC) invariably remains the most lethal gynecological malignancy in women. In the absence of biomarkers capable of detecting EOC at an early, still curable stage, altered glycosylation of proteins attracted attention as a potential source …

    fu-berlin Repository record for N-Glycosylation signatures of epithelial ovarian cancer (opens in a new tab)

  2. Role of age in epithelial ovarian cancer

    … clinical outcome and survival of patients with epithelial ovarian cancer. The study cohort consisted of 446 women treated between September 2000 and April 2006 in the clinic for Gynecology, Campus Virchow-Klinikum, Charité Berlin. All clinical data were provided by the Tumor Bank Ovarian Cancer …

    fu-berlin Repository record for Role of age in epithelial ovarian cancer (opens in a new tab)

  3. Modeling Epithelial Ovarian Cancer In The Mouse

    For over five decades epithelial ovarian cancer (EOC) is identified as the leading cause of death from gynecological malignancies in the USA. Unfortunately, due to latent progression of EOC and lack of accurate animal models studies of this disease's pathogenesis have been challenging. Not …

    cornell Repository record for Modeling Epithelial Ovarian Cancer In The Mouse (opens in a new tab)

  4. Targeted alpha therapy for epithelial ovarian cancer

    Purpose: Control of micrometastatic ovarian cancer in the peritoneal cavity remains a major objective in post-surgical treatment. The purpose of this project was to investigate the efficacy and toxicity of targeted alpha therapy (TAT) for ovarian cancer in vitro and in vivo in animal models and to …

    unsw Repository record for Targeted alpha therapy for epithelial ovarian cancer (opens in a new tab)

  5. Serum-based N-glycan biomarker for diagnosis of epithelial ovarian cancer. The ascites N-glycome of epithelial ovarian cancer.

    … for the diagnosis of multiple diseases including cancer and inflammation. Serum is the liquid fraction that is obtained after whole blood has been allowed to clot. It is considered to be a biological fluid suitable for biomarker discovery as it is relatively stable under various conditions as well …

    fu-berlin Repository record for Serum-based N-glycan biomarker for diagnosis of epithelial ovarian cancer. The ascites N-glycome of epithelial ovarian cancer. (opens in a new tab)

  6. ABCA1 promotes aggressive characteristics in epithelial ovarian cancer

    Epithelial ovarian cancer (EOC) is a devastating disease, which accounts for a large proportion of gynaecological cancer-related deaths. Poor survival is largely due to late diagnosis of the disease, typically with tumour dissemination. In order to reduce tumour burden and improve survival, it is …

    unsw Repository record for ABCA1 promotes aggressive characteristics in epithelial ovarian cancer (opens in a new tab)

  7. Shift Work Patterns and Epithelial Ovarian Cancer Risk

    … can influence hormone levels that may affect ovarian cancer risk. Few studies have examined the relationship between shift work and ovarian cancer risk, thus, more research is required in this area. The association between shift work exposure and epithelial ovarian cancer (EOC) risk, as well …

    queens Repository record for Shift Work Patterns and Epithelial Ovarian Cancer Risk (opens in a new tab)

  8. Inflammatory Factor and Biomarkers for Epithelial Ovarian Cancer

    While ovarian cancer is the second most common gynecological cancer, it is the fifth leading cause of cancer-related deaths in the US. Due to a lack of adequate screening tools, it is imperative to develop innovative methods to identify women at greater risk of developing invasive epithelial …

    buffalo Repository record for Inflammatory Factor and Biomarkers for Epithelial Ovarian Cancer (opens in a new tab)

  9. Oestrogen metabolism and action in epithelial ovarian cancer

    Ovarian cancer is the most fatal of all gynecological malignancies. Epithelial ovarian cancer (EOC) accounts for about 90% of malignant ovarian tumours and is thought to originate mostly from ovarian surface epithelium (OSE) cells. Epidemiological data suggest that hormone replacement treatment …

    edinburgh Repository record for Oestrogen metabolism and action in epithelial ovarian cancer (opens in a new tab)

  10. Investigation of novel therapeutic strategies for epithelial ovarian cancer

    … the anti-tumour activity of PRIMA-1MET on epithelial ovarian cancer (EOC) cells and elucidate the underlying mechanism in vitro. Methods: We used nine EOC cell lines and their chronic cisplatin/paclitaxel-resistant cells and performed cell viability assay and cell apoptosis assay to …

    adelaide Repository record for Investigation of novel therapeutic strategies for epithelial ovarian cancer (opens in a new tab)

  11. Potential Roles Of Circska3 In Epithelial Ovarian Cancer Development

    Ovarian cancer (OC) is the deadliest gynecologic cancer, of which epithelial ovarian cancer (EOC) is the most prevalent and aggressive form. Circular RNAs (circRNAs) have emerged as potential therapeutic targets and biomarkers in various cancers, including EOC. This study investigated circSKA3, …

    york Repository record for Potential Roles Of Circska3 In Epithelial Ovarian Cancer Development (opens in a new tab)

  12. The Effects of Oscillatory Forces on Epithelial Ovarian Cancer

    … flow, and body movement are present throughout ovarian tumors. These forces have been shown to strongly regulate mechanotransduction signaling, leading to tumor progression, metastasis, and invasion. Mechanotransduction studies are rarely conducted in ovarian cancer. This study is the first of …

    uab Repository record for The Effects of Oscillatory Forces on Epithelial Ovarian Cancer (opens in a new tab)

  13. Intrinsic subtypes and prognostic implications in epithelial ovarian cancer

    Ovarian cancer is the seventh most common cancer in women globally, with approximately 240,000 new cases annually. Although a rare disease, it is the most lethal gynecologic malignancy. Unspecific symptoms result in late diagnosis and a generally poor prognosis. However, ovarian cancer is a …

    lund Repository record for Intrinsic subtypes and prognostic implications in epithelial ovarian cancer (opens in a new tab) Download PDF for Intrinsic subtypes and prognostic implications in epithelial ovarian cancer (opens in a new tab)

  14. Identification of Novel Prognostic Biomarkers in Epithelial Ovarian Cancer

    The research in this dissertation demonstrates that, in a larger study adjusting for clinical covariates, circulating, immunophenotypically defined M-MDSCs may be an independent prognostic biomarker for EOC. Identifying this association in the peripheral blood of EOC patients offers a non-invasive …

    buffalo Repository record for Identification of Novel Prognostic Biomarkers in Epithelial Ovarian Cancer (opens in a new tab)

  15. Factor XIIIA Genotypes to Outcome in Epithelial Ovarian Cancer

    Epithelial ovarian cancer (EOC) is often diagnosed at the more aggressive stages of disease and its heterogeneity makes treatment challenging. Factor XIIIA (FXIIIA) is a transglutaminase which crosslinks fibrin to form stable blood clots, as well as having other roles in inflammation and …

    whiterose Download PDF for Factor XIIIA Genotypes to Outcome in Epithelial Ovarian Cancer (opens in a new tab)

  16. NON-CODING RNAS IN HIGH-GRADE SEROUS EPITHELIAL OVARIAN CANCER

    Abstract Introduction: High-grade serous ovarian carcinoma (HGSOC) is the most lethal gynecologic malignancy, mainly because the disease is frequently diagnosed at an advanced stage and is characterized by the early onset of chemoresistant recurrences. The lack of reliable diagnostic and prognostic …

    milano Repository record for NON-CODING RNAS IN HIGH-GRADE SEROUS EPITHELIAL OVARIAN CANCER (opens in a new tab)

  17. Targeting Metabolic Vulnerabilities In Epithelial Ovarian Cancer Via Folate Transporters

    Novel therapies are urgently needed for epithelial ovarian cancer (EOC), the most lethal gynecologic malignancy. In addition, therapies which target a unique vulnerability in the tumor microenvironment (TME) of EOC have largely been unrealized. It is known the major infiltrating immune population …

    wayne-thes Repository record for Targeting Metabolic Vulnerabilities In Epithelial Ovarian Cancer Via Folate Transporters (opens in a new tab)

  18. Lifetime Caffeine Intake and the Risk of Epithelial Ovarian Cancer

    … between lifetime caffeine intake and the risk of epithelial ovarian cancer (EOC) overall, according to tumour behaviour (invasive vs. borderline), and by invasive tumour type (Type I vs. Type II) and to assess menopausal status as an effect modifier. Methods: The PRevention of OVArian Cancer in …

    queens Repository record for Lifetime Caffeine Intake and the Risk of Epithelial Ovarian Cancer (opens in a new tab)

  19. The Effects of 3TSR Fusion Proteins on Epithelial Ovarian Cancer

    Epithelial ovarian cancer is the most common and most deadly of the gynecological disorders, with late stage detection and inadequate treatment options contributing to its high mortality rate. Angiogenesis is a key mediator of cancer development, and as such represents an attractive therapeutic …

    guelph Repository record for The Effects of 3TSR Fusion Proteins on Epithelial Ovarian Cancer (opens in a new tab)

Page 1 of 13